These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34429024)

  • 1. Pharmacist Views Regarding the Prescription Opioid Epidemic.
    Rao D; Giannetti V; Kamal KM; Covvey JR; Tomko JR
    Subst Use Misuse; 2021; 56(14):2096-2105. PubMed ID: 34429024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "The gatekeepers in prevention": Community pharmacist perceptions of their role in the opioid epidemic.
    Vadiei N; Eldridge LA; Meyerson BE; Agley J
    Subst Abus; 2022; 43(1):319-327. PubMed ID: 34214407
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring perspectives on changing opioid prescribing practices: A qualitative study of community stakeholders in the HEALing Communities Study.
    Walker DM; Childerhose JE; Chen S; Coovert N; Jackson RD; Kurien N; McAlearney AS; Volney J; Alford DP; Bosak J; Oyler DR; Stinson LK; Behrooz M; Christopher MC; Drainoni ML
    Drug Alcohol Depend; 2022 Apr; 233():109342. PubMed ID: 35151024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are pharmacists on the front lines of the opioid epidemic? A cross-sectional study of the practices and competencies of community and hospital pharmacists in Punjab, Pakistan.
    Mubarak N; Zahid T; Rana FR; Ijaz UE; Shabbir A; Manzoor M; Khan N; Arif M; Naeem MM; Kanwal S; Saif-Ur-Rehman N; Zin CS; Mahmood K; Asgher J; Elnaem MH
    BMJ Open; 2023 Nov; 13(11):e079507. PubMed ID: 37989383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing Opioid Prescribing in Surgery (MOPiS) Initiative: An Analysis of Implementation Barriers.
    Coughlin JM; Shallcross ML; Schäfer WLA; Buckley BA; Stulberg JJ; Holl JL; Bilimoria KY; Johnson JK
    J Surg Res; 2019 Jul; 239():309-319. PubMed ID: 30908977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.
    Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Ratliff B; Hagaman A; Pack RP
    Subst Abus; 2018 Jan; 39(1):89-94. PubMed ID: 28799863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing opioid prescribing and pain treatment for surgery: Review and conceptual framework.
    Bicket MC; Brat GA; Hutfless S; Wu CL; Nesbit SA; Alexander GC
    Am J Health Syst Pharm; 2019 Sep; 76(18):1403-1412. PubMed ID: 31505561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of opioid crisis and the role of pharmacist-led interventions.
    Sanyal C
    J Am Pharm Assoc (2003); 2021; 61(3):e70-e74. PubMed ID: 33279425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriber and pharmacist understanding of revised Rhode Island pain management regulations.
    Rogala BG; Jarvais A; Ng T; Bratberg J
    J Oncol Pharm Pract; 2021 Apr; 27(3):601-608. PubMed ID: 32517637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drivers, Beliefs, and Barriers Surrounding Surgical Opioid Prescribing: A Qualitative Study of Surgeons' Opioid Prescribing Habits.
    Sceats LA; Ayakta N; Merrell SB; Kin C
    J Surg Res; 2020 Mar; 247():86-94. PubMed ID: 31767277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' preparedness to intervene with concerns around prescription opioids: findings from a nationally representative survey.
    Alvin M; Picco L; Wood P; Mnatzaganian G; Nielsen S
    Int J Clin Pharm; 2021 Apr; 43(2):411-419. PubMed ID: 32951182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
    Faller RW; Erausquin JT; McCoy TP
    Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
    Jacobs SC; Son EK; Tat C; Chiao P; Dulay M; Ludwig A
    Subst Abus; 2016; 37(1):15-9. PubMed ID: 26675444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An opioid dispensing and misuse prevention algorithm for community pharmacy practice.
    Rickles NM; Huang AL; Gunther MB; Chan WJ
    Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Patients' Perceived Difficulties Filling Opioid Prescriptions After Receiving Outpatient Supportive Care.
    Brown JH; Torres HP; Maddi RD; Williams JL; Dibaj SS; Liu D; Bruera E
    J Pain Symptom Manage; 2020 Nov; 60(5):915-922. PubMed ID: 32569832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Pharmacist in Combating the Opioid Crisis: An Update.
    Kosobuski L; O'Donnell C; Koh-Knox Sharp CP; Chen N; Palombi L
    Subst Abuse Rehabil; 2022; 13():127-138. PubMed ID: 36597518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.